Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Low-dose Aspirin prevents hypertension and cardiac fibrosis when thromboxane A2 is unrestrained

Pharmacological Research(2021)10.1016/j.phrs.2021.105744Source: DataRank Database

Low-dose Aspirin prevents hypertension and cardiac fibrosis when thromboxane A2 is unrestrained is a research paper published in Pharmacological Research (2021). On theSindex it has a DataRank of 0. It has been cited 30 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access30 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: hybridTopics (57)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Stefania Tacconelli ORCID,Annalisa Bruno,Annalisa Contursi,Luciana Mucci,Xiaoyue Hu ORCID

Live enrichment

PubMed:34182131

National Heart, Lung, and Blood Institute

Grant: R01HL115247

National Heart, Lung, and Blood Institute

Grant: R01HL122815

National Heart, Lung, and Blood Institute

Grant: R01HL150515

Ministero dell'Istruzione dell'Università e della Ricerca

Grant: unidentified

unidentified

National Institutes of Health

Grant: 3R01HL115247-08S1

Hyperglycemia, aldose reductase, miRNA and cardiovascular disease in diabetes mellitus

National Institutes of Health

Grant: 1R01HL122815-01A1

Platelet Mitochondrial Function in Health and Disease

National Institutes of Health

Grant: 5R01HL150515-03

Platelets in vascular injury repair

hybridLicense: cc-by-nc-nd

publisherhttps://www.sciencedirect.com/science/article/pii/S1043661821003285/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1043661821003285?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1043661821003285?httpAccept=text/plain

repositoryhttps://www.openaccessrepository.it/record/87065

Unpaywallhttps://doi.org/10.1016/j.phrs.2021.105744

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicine0303 health sciences

MeSH Terms

Blood PlateletsCells, CulturedMyocytes, CardiacAnimalsMice, Inbred C57BLMice, KnockoutHumansMiceCardiomyopathiesDisease Models, AnimalFibrosisAspirinThromboxane A2Receptors, EpoprostenolReceptors, ThromboxaneAntihypertensive AgentsPlatelet Aggregation InhibitorsCase-Control StudiesBlood PressureAdultMiddle AgedFemaleMaleMyofibroblastsBiomarkersEssential HypertensionAntifibrotic Agents

Keywords

HypertensionProstacyclinThromboxaneaspirinCardiac FibrosisAdultBlood PlateletsMaleBlood PressureAspirin; Cardiac fibrosis; Hypertension; Prostacyclin; ThromboxaneAnimalsHumansAntihypertensive AgentsCells, CulturedPharmacologyMice, KnockoutMiddle AgedFibrosisMice, Inbred C57BLDisease Models, AnimalCase-Control StudiesFemaleAntifibrotic AgentsEssential HypertensionCardiomyopathiesBiomarkers

Sustainable Development Goals

SDG 3: 3. Good health